Rapamune Alternatives Compared
| Rapamune Remove Rapamune from your drug comparison | Sirolimus Remove Sirolimus from your drug comparison | CellCept Remove CellCept from your drug comparison |
|---|
| Rapamune sirolimus Remove Rapamune from your drug comparison | Sirolimus Remove Sirolimus from your drug comparison | CellCept mycophenolate mofetil Remove CellCept from your drug comparison | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Lymphangioleiomyomatosis, Organ Transplant - Rejection Prophylaxis. Rapamune may also be used for purposes not listed in this medication guide. |
Prescribed for Lymphangioleiomyomatosis, Organ Transplant - Rejection Prophylaxis. sirolimus may also be used for purposes not listed in this medication guide. |
Prescribed for Nephrotic Syndrome, Organ Transplant - Rejection Prophylaxis. CellCept may also be used for purposes not listed in this medication guide. |
||||||||||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
Ratings & Reviews |
||||||||||||||||||||||||||
Drug Class |
||||||||||||||||||||||||||
Side Effects |
||||||||||||||||||||||||||
|
Common side effects include: upper respiratory tract infection, urinary tract infection. See the full Rapamune side effects document. |
Commonly reported side effects include: upper respiratory tract infection, urinary tract infection. See the full sirolimus side effects document. |
Common side effects include: asthma, herpes simplex infection, infection, metabolic acidosis, oral candidiasis, pleural effusion, respiratory tract infection, systemic cytomegalovirus disease, urinary tract infection, viremia, abdominal pain, acne vulgaris, anemia, anxiety, asthenia, back pain, cardiovascular disorder, chest pain, constipation, cough, depression, diarrhea, disorder of integument, drowsiness, dyspepsia, dyspnea, edema, fever, headache, hypercholesterolemia, hyperlipidemia, hypertension, hypertonia, hyperuricemia, hypervolemia, hypokalemia, hypotension, increased lactate dehydrogenase, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, increased serum creatinine, leukopenia, lower limb cramp, myalgia, myasthenia, nausea, pain, paresthesia, peripheral edema, pulmonary disease, rhinitis, sinusitis, tachycardia, thrombocytopenia, tremor, vomiting, weight gain, chills, flatulence. See the full CellCept side effects document. |
||||||||||||||||||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||||||||||||||||||
View all Rapamune prices and generic prices |
View all sirolimus prices |
View all CellCept prices and generic prices |
||||||||||||||||||||||||
Generic Availability |
||||||||||||||||||||||||||
|
Yes (this medicine) |
||||||||||||||||||||||||||
Dosage Form(s) Available |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names |
||||||||||||||||||||||||||
|
N/A |
Rapamune |
N/A |
||||||||||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||||||||||||||||||
|
78 hours |
78 hours |
18 hours |
||||||||||||||||||||||||
CSA Schedule**View glossary of terms. |
||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category |
||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
Drug Interactions |
||||||||||||||||||||||||||
|
A total of 591 drugs are known to interact with Rapamune:
|
A total of 591 drugs are known to interact with sirolimus:
|
A total of 282 drugs are known to interact with CellCept:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions |
||||||||||||||||||||||||||
First Approval Date |
||||||||||||||||||||||||||
|
September 15, 1999 |
September 15, 1999 |
May 03, 1995 |
||||||||||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information |
||||||||||||||||||||||||||
Consumer Resources |
||||||||||||||||||||||||||
Professional Resources |
||||||||||||||||||||||||||
Related Treatment Guide |
||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.